Attributes | Values |
---|
rdf:type
| |
description
| - wetenschappelijk artikel (nl)
- bài báo khoa học (vi)
- article scientifique publié en 2005 (fr)
- наукова стаття, опублікована в лютому 2005 (uk)
- artículu científicu espublizáu en febreru de 2005 (ast)
- artikull shkencor i botuar më 01 shkurt 2005 (sq)
- scientific article published on 01 February 2005 (en)
|
publication date
| |
publication date
| |
author name string
| |
author name string
| - R Liang
- A K W Lie
- W-Y Au
- Y-L Kwong
- A Y H Leung
- C Choy
- F Loong
- C C K Lam
- C-C Yau
- S-Y Ma
|
rdfs:label
| - Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (en)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (nl)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (sq)
|
skos:prefLabel
| - Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (en)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (nl)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (sq)
|
name
| - Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (en)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (nl)
- Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (sq)
|
author
| |
author
| |
title
| |
title
| - Clinicopathologic features and treatment outcome of mature T-cell and natural killer-cell lymphomas diagnosed according to the World Health Organization classification scheme: a single center experience of 10 years (en)
|
page(s)
| |
page(s)
| |
instance of
| |
instance of
| |
main subject
| |
main subject
| |
PubMed ID
| |
PubMed ID
| |
PubMed ID
| |
published in
| |
published in
| |
issue
| |
volume
| |
issue
| |
volume
| |
DOI
| |
DOI
| |
DOI
| |
is about
of | |
is cites work
of | - Aberrant antigenic expression in extranodal NK/T-cell lymphoma: a multi-parameter study from Thailand
- Extranodal NK/T-cell lymphoma: diagnosis and treatment cues.
- Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma
- Peripheral T cell lymphoma, not otherwise specified: the stuff of genes, dreams and therapies.
- Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma
- Common misdiagnoses in lymphomas and avoidance strategies
- The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas
- Histological vascular invasion is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
- Non-anaplastic peripheral t-cell lymphoma in childhood and adolescence: a Children's Oncology Group study
- Aggressive mature natural killer cell neoplasms: from epidemiology to diagnosis
- Natural killer-cell malignancies: diagnosis and treatment
- High numbers of tumor-associated macrophages correlate with poor prognosis in patients with mature T- and natural killer cell lymphomas
- Extranodal natural-killer/t-cell lymphoma, nasal type
- Management of T-cell and natural-killer-cell neoplasms in Asia: consensus statement from the Asian Oncology Summit 2009.
- PET/CT aids the staging of and radiotherapy planning for early-stage extranodal natural killer/T-cell lymphoma, nasal type: a case series
- Recurrent Natural Killer Cell Lymphoma with Central Nervous System Metastasis Mimicking Cerebellar Infarction
- Deciphering the role of Epstein-Barr virus in the pathogenesis of T and NK cell lymphoproliferations
- High-dose chemotherapy with autologous stem cell transplantation in extranodal NK/T-cell lymphoma: a retrospective comparison with non-transplantation cases
- Prognostic value of whole-body SUVmax of nodal and extra-nodal lesions detected by 18F-FDG PET/CT in extra-nodal NK/T-cell lymphoma
- Subtype distribution of lymphomas in Southwest China: analysis of 6,382 cases using WHO classification in a single institution
- Clinical study of l-asparaginase in the treatment of extranodal NK/T-cell lymphoma, nasal type
- Phase 2 trial of "sandwich" L-asparaginase, vincristine, and prednisone chemotherapy with radiotherapy in newly diagnosed, stage IE to IIE, nasal type, extranodal natural killer/T-cell lymphoma
- Chidamide in the treatment of peripheral T-cell lymphoma
- Epstein-Barr Virus-associated lymphoproliferative disorders: experimental and clinical developments
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United States
- Extranodal natural killer/T-cell lymphoma in Malawi: a report of three cases
- Pulmonary Extranodal Natural Killer/T-Cell Lymphoma (Nasal Type): A Case Report and Radiological Image Review
- The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment
- CD30 expression is a novel prognostic indicator in extranodal natural killer/T-cell lymphoma, nasal type
- Panobinostat in combination with bortezomib in patients with relapsed or refractory peripheral T-cell lymphoma: an open-label, multicentre phase 2 trial
- A phase II prospective study of the "Sandwich" protocol, L-asparaginase, cisplatin, dexamethasone and etoposide chemotherapy combined with concurrent radiation and cisplatin, in newly diagnosed, I/II stage, nasal type, extranodal natural killer/T-ce
- A phase 2 study of methotrexate, etoposide, dexamethasone, and pegaspargase chemotherapy for newly diagnosed, relapsed, or refractory extranodal natural killer/T-cell lymphoma, nasal type: a multicenter trial in Northwest China.
- Primary systemic anaplastic large cell lymphoma in Korean adults: 11 years' experience at Asan Medical Center
- Epstein-barr virus and the pathogenesis of T and NK lymphoma: a mystery unsolved.
- Utility of PET/CT in the diagnosis and staging of extranodal natural killer/T-cell lymphoma: a systematic review and meta-analysis
- Prognostic value of baseline, interim and end-of-treatment 18F-FDG PET/CT parameters in extranodal natural killer/T-cell lymphoma: A meta-analysis.
|